OGN News and Press, Organon & Co. From 12/13/21

Organon has seen material share price weakness as of late. The selling appears to be unjustified, however, considering Organon's recent business fundamentals. Meanwhile, OGN pays a respectable dividend with a low payout ratio, and has growth catalysts in its Women's Health and Bio...

Organon fell after posting quarterly results. Shareholders are nervous about recent acquisition. Fair value introduced. For further details see: Why Buy Organon After Shares Fell Below $30

Organon & Co. (OGN) 4th Annual Evercore ISI HealthCONx Conference December 1, 2021 1:50 PM ET Company Participants Kevin Ali - CEO Matthew Walsh - CFO Conference Call Participants Umer Raffat - Evercore Eric Musonza - Evercore Presentation Umer Raffat 00:00 Hello, everyone. Thank you for ...

Merck continues to impress with strong growth in its key franchises. It maintains a very strong balance sheet, and just increased its dividend, which remains well-covered by earnings. Recent perceived headwinds have driven the share price back to bargain territory. For furth...

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1, 2021 at 1:50 p.m. ET. Investors, a...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Spin-off stocks have been in the limelight in recent weeks. For instance, Johnson & Johnson (NYSE: JNJ ) recently announced it will spin off its consumer health division and instead focus on pharmaceuticals an...

Berkshire Hathaway's 13F stock portfolio value remained almost steady at ~$293B. Their largest three holdings are at two-thirds of the entire portfolio. Berkshire Hathaway increased Chevron while reducing Charter Communications, AbbVie, Marsh & McLennan, and Bristol-Myers Squi...

Glenview Capital takes new stakes in CCC Intelligent Solutions (NYSE:CCCS) with 2.41M shares, Willis Towers Watson (NASDAQ:WLTW) with 833K shares, and Organon (NYSE:OGN) with 753K shares. Exits Walgreens Boots Alliance (NASDAQ:WBA), Quantum-Si (NASDAQ:QSI), and Medtronic (NYSE:MDT). Boosts st...

Organon was formed via the spin-out of Merck's Women's Health, Biosimilars and Established Brands divisions - shares began trading in May. On Nov. 11, the company reported Q321 earnings, affirming FY21 guidance for $6.2-$6.3bn. Based on nine-month performance, Organon ought to be ...

Organon & Co. (OGN) Q3 Earnings Conference Call November 11, 2021, 8:30 AM ET Company Participants Kevin Ali – Chief Executive Officer Jennifer Halchak – Vice President, Investor Relations Matt Walsh – Chief Financial Officer Conference Call Participants Chris Schott ...